| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2018 | 21ST CENTURY THERAPEUTICS, INC. | 440 BURROUGHS ST STE 100 | DETROIT | MI | 48202-3428 | WAYNE | USA | R43HL139196 | Development of a Novel Small Molecule as a Radioprotector for Total Body Irradiation | 000 | 1 | NIH | 4/30/2020 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $345,914 ) |
| | 2018 | 2018 | 21ST CENTURY THERAPEUTICS, INC. | 440 BURROUGHS ST STE 100 | DETROIT | MI | 48202-3428 | WAYNE | USA | R43HL139196 | Development of a Novel Small Molecule as a Radioprotector for Total Body Irradiation | 000 | 1 | NIH | 9/16/2018 | $345,914 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2015 | 21ST CENTURY THERAPEUTICS, INC. | 440 BURROUGHS ST STE 100 | DETROIT | MI | 48202-3428 | WAYNE | USA | R43AT008202 | Novel Compounds from Sycamore Leaves for the Treatment of MRSA | 000 | 1 | NIH | 1/9/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $4,784 ) |
| | 2016 | 2016 | 21ST CENTURY THERAPEUTICS INC | 52623 SEVEN OAKS | SHELBY TOWNSHIP | MI | 48316 | MACOMB | USA | R43AT008202 | Novel Compounds from Sycamore Leaves for the Treatment of MRSA | 000 | 1 | NIH | 11/23/2015 | $4,784 |
|
| Issue Date FY: 2015 ( Subtotal = $639,485 ) |
| | 2015 | 2015 | 21ST CENTURY THERAPEUTICS INC | 52623 SEVEN OAKS | SHELBY TOWNSHIP | MI | 48316 | MACOMB | USA | R43GM109528 | Development of a Novel ELISA Kit for Screening Potential JAK3 Inhibitors | 000 | 2 | NIH | 5/8/2015 | $335,740 |
| | 2015 | 2015 | 21ST CENTURY THERAPEUTICS INC | 52623 SEVEN OAKS | SHELBY TOWNSHIP | MI | 48316 | MACOMB | USA | R43AT008202 | Novel Compounds from Sycamore Leaves for the Treatment of MRSA | 000 | 1 | NIH | 8/10/2015 | $303,745 |
|
| Issue Date FY: 2014 ( Subtotal = $338,736 ) |
| | 2014 | 2014 | 21ST CENTURY THERAPEUTICS INC | 52623 SEVEN OAKS | SHELBY TOWNSHIP | MI | 48316 | MACOMB | USA | R43GM109528 | Development of a Novel ELISA Kit for Screening Potential JAK3 Inhibitors | 000 | 1 | NIH | 6/4/2014 | $338,736 |
|
| Issue Date FY: 2013 ( Subtotal = $276,418 ) |
| | 2013 | 2013 | 21ST CENTURY THERAPEUTICS INC | 52623 SEVEN OAKS | SHELBY TOWNSHIP | MI | 48316 | MACOMB | USA | R43CA174007 | DEVELOPMENT OF A NOVEL SMALL MOLECULE, UTL-5G, TO TREAT OXALIPLATIN-INDUCED THROM | 000 | 1 | NIH | 4/25/2013 | $276,418 |
|
| Issue Date FY: 2012 ( Subtotal = $542,156 ) |
| | 2012 | 2012 | 21ST CENTURY THERAPEUTICS INC | 52623 SEVEN OAKS | SHELBY TOWNSHIP | MI | 48316 | MACOMB | USA | R44CA141749 | NOVEL SMALL-MOLECULE TNF-A MODULATORS AS CHEMOPROTECTIVE AGENTS | 000 | 3 | NIH | 8/21/2012 | $542,156 |
|
| Issue Date FY: 2011 ( Subtotal = $591,522 ) |
| | 2011 | 2011 | 21ST CENTURY THERAPEUTICS INC | 52623 SEVEN OAKS | SHELBY TOWNSHIP | MI | 48316 | MACOMB | USA | R44CA141749 | NOVEL SMALL-MOLECULE TNF-A MODULATORS AS CHEMOPROTECTIVE AGENTS | 000 | 2 | NIH | 8/23/2011 | $591,522 |
|
| Issue Date FY: 2009 ( Subtotal = $154,852 ) |
| | 2009 | 2009 | 21ST CENTURY THERAPEUTICS INC | 52623 SEVEN OAKS | SHELBY TOWNSHIP | MI | 48316 | MACOMB | USA | R43CA141749 | NOVEL SMALL-MOLECULE TNF-A MODULATORS AS CHEMOPROTECTIVE AGENTS | 000 | 1 | NIH | 7/14/2009 | $154,852 |
|
| Issue Date FY: 2005 ( Subtotal = $192,512 ) |
| | 2005 | 2005 | 21ST CENTURY THERAPEUTICS INC | 52623 SEVEN OAKS | SHELBY TOWNSHIP | MI | 48316 | MACOMB | USA | R43CA110433 | SYNTHESIS/IN VIVO ACTIVITY OF CYCLOCINAMIDE A | 000 | 1 | NIH | 9/26/2005 | $192,512 |
|
|
